Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-10-3
pubmed:abstractText
Few and contrasting data are available on the prevalence of hemostatic risk factors in patients with central retinal vein occlusion (CRVO). Aim of this study was to investigate the metabolic and inherited risk factors for venous thrombosis in 100 CRVO patients (age: 59 yrs; range 18-77) and in 100 controls (age: 56 yrs; range 18-84). In patients homocysteine (Hcy) levels were significantly higher than in controls and were affected by the C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism (p < 0.001). The prevalences of activated protein C resistance (APCR), factor V Leiden positivity, elevated PAI-1 and Lp(a) levels were significantly higher in patients with respect to controls. At multivariate analysis, only hyperhomocysteinemia (OR 11, 95% CI 3.6-36.2; p < 0.0001) and elevated PAI-1 levels (OR 8.9, 95% CI 3.5-41.3; p < 0.01), in addition to hypertension (OR 40.5, 95% CI 8.6-188.8; p < 0.00001) and hypercholesterolemia (OR 3.1, 95% CI 1.6-20.5; p < 0.05), were independent risk factors for CRVO. These data demonstrate a potential role of hemostatic risk factors in the pathophysiology of CRVO.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0340-6245
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
772-6
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:11583306-Adolescent, pubmed-meshheading:11583306-Adult, pubmed-meshheading:11583306-Aged, pubmed-meshheading:11583306-Blood Coagulation Factors, pubmed-meshheading:11583306-Cerebrovascular Disorders, pubmed-meshheading:11583306-Comorbidity, pubmed-meshheading:11583306-Coronary Disease, pubmed-meshheading:11583306-Diabetes Mellitus, pubmed-meshheading:11583306-Factor V, pubmed-meshheading:11583306-Female, pubmed-meshheading:11583306-Genetic Predisposition to Disease, pubmed-meshheading:11583306-Hemostasis, pubmed-meshheading:11583306-Humans, pubmed-meshheading:11583306-Hypercholesterolemia, pubmed-meshheading:11583306-Hyperhomocysteinemia, pubmed-meshheading:11583306-Hypertension, pubmed-meshheading:11583306-Male, pubmed-meshheading:11583306-Methylenetetrahydrofolate Reductase (NADPH2), pubmed-meshheading:11583306-Middle Aged, pubmed-meshheading:11583306-Oxidoreductases Acting on CH-NH Group Donors, pubmed-meshheading:11583306-Point Mutation, pubmed-meshheading:11583306-Prospective Studies, pubmed-meshheading:11583306-Prothrombin, pubmed-meshheading:11583306-Retinal Vein Occlusion, pubmed-meshheading:11583306-Risk Factors, pubmed-meshheading:11583306-Smoking, pubmed-meshheading:11583306-Thrombophilia, pubmed-meshheading:11583306-Venous Thrombosis
pubmed:year
2001
pubmed:articleTitle
Thrombophilic risk factors in patients with central retinal vein occlusion.
pubmed:affiliation
Dept Area Critica Medico-Chirurgica, Thrombosis Center, Az Ospedaliera Careggi, University of Florence, Italy.
pubmed:publicationType
Journal Article